Safety and administration The evidence in human trials shows AOD 9604 as safe for human consumption
for neutral grounding on indications and biology, see Vitamin B12 Health Professional Fact Sheet , which outlines deficiency care and dosing context for clinicians
It is a small molecule, specifically a quinolinium-based selective inhibitor of the NNMT enzyme
The randomized, double-blind, placebo-controlled, multicentre Phase 2 study enrolled 263 adults with obesity or overweight plus at least one obesity-related comorbidity, without type 2 diabetes, and ran 48 weeks
Dose Range: 2.55 mg once or twice daily
Key Differences Between Tesamorelin and AOD 9604 What to Look For in Research-Grade Peptides Synthetic peptides are fragile